A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data
**Background:** Trial data often does not cover a sufficiently long period of time to truly capture time-toevent endpoints, however, Health Technology Assessment (HTA) bodies often require overall survival (OS) and progression-free survival (PFS) estimates. Often, significant survival effects are fo...
Main Authors: | Gabriel Tremblay, Patrick Haines, Andrew Briggs |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | http://jheor.scholasticahq.com/article/9896-a-criterion-based-approach-for-the-systematic-and-transparent-extrapolation-of-clinical-trial-survival-data.pdf |
Similar Items
-
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
by: Tremblay G, et al.
Published: (2016-06-01) -
Applications and Comparisons of Survival Extrapolation Methods
by: Yi-Hui Liu, et al.
Published: (2016) -
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
by: Benjamin Li, et al.
Published: (2020-06-01) -
Data Extrapolation in the FDTD Method
by: Zhi-yang Lan, et al.
Published: (2004) -
Transparency in clinical trials
by: Miguel Araujo Alonso
Published: (2013-04-01)